210 related articles for article (PubMed ID: 6203825)
1. Significance of the 'maturation' of metastases from germ cell tumours after intensive chemotherapy.
McCartney AC; Paradinas FJ; Newlands ES
Histopathology; 1984 May; 8(3):457-67. PubMed ID: 6203825
[TBL] [Abstract][Full Text] [Related]
2. [Histopathology of testicular germ cell tumors].
Morinaga S; Sasano N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
[TBL] [Abstract][Full Text] [Related]
3. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
Wittekind C; Wichmann T; Von Kleist S
Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours.
Harms D; Jänig U
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):223-39. PubMed ID: 2424170
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers and pathology of testicular tumors.
Mostofi FK
Prog Clin Biol Res; 1984; 153():69-87. PubMed ID: 6206511
[TBL] [Abstract][Full Text] [Related]
7. Current concepts on the histogenesis, pathology, and immunochemistry of germ cell tumors of the testis.
Nochomovitz LE; Rosai J
Pathol Annu; 1978; 13 Pt 1():327-62. PubMed ID: 82931
[No Abstract] [Full Text] [Related]
8. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
9. Extragonadal testicular tumors.
Utz DC; Buscemi MF
J Urol; 1971 Feb; 105(2):271-4. PubMed ID: 4326252
[No Abstract] [Full Text] [Related]
10. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
[TBL] [Abstract][Full Text] [Related]
11. Therapy of extragonadal germ-cell tumors.
Daugaard G; Rørth M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):895-9. PubMed ID: 6192996
[TBL] [Abstract][Full Text] [Related]
12. Germ cell tumours.
Talerman A
Ann Pathol; 1985; 5(3):145-57. PubMed ID: 3000396
[TBL] [Abstract][Full Text] [Related]
13. Histogenetic considerations concerning germ cell tumours. Morphological and immunohistochemical comparative investigation of the human embryo and testicular germ cell tumours.
Jacobsen GK
Virchows Arch A Pathol Anat Histopathol; 1986; 408(5):509-25. PubMed ID: 2420062
[TBL] [Abstract][Full Text] [Related]
14. Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours.
O'Reilly SM; Rustin GJ; Smith DB; Newlands ES
Ann Oncol; 1992 Feb; 3(2):163-4. PubMed ID: 1376619
[TBL] [Abstract][Full Text] [Related]
15. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
Jacobsen GK; Olsen J
Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in the pathology of germ cell tumors.
Ulbright TM; Roth LM
Semin Diagn Pathol; 1987 Nov; 4(4):304-19. PubMed ID: 2832917
[TBL] [Abstract][Full Text] [Related]
17. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.
Talerman A; Haije WG; Baggerman L
Cancer; 1980 Jul; 46(2):380-5. PubMed ID: 6155988
[TBL] [Abstract][Full Text] [Related]
18. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
[TBL] [Abstract][Full Text] [Related]
19. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
McAleer JJ; Nicholls J; Horwich A
Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
[TBL] [Abstract][Full Text] [Related]
20. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
